Trevi Therapeutics, Inc.

GEODE CAPITAL MANAGEMENT, LLC TRVI

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/9/2026

Shares

2,412,885

Value ($000)

30,214

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/9/2026	30,214	0.0%	2,412,885	12/31/2025
2025 Q3	11/12/2025	20,326	0.0%	2,220,926	9/30/2025
2025 Q2	8/8/2025	9,776	0.0%	1,786,845	6/30/2025
2025 Q1	5/13/2025	10,160	0.0%	1,614,865	3/31/2025
2024 Q4	2/12/2025	5,354	0.0%	1,299,322	12/31/2024
2024 Q3	11/12/2024	4,223	0.0%	1,264,166	9/30/2024
2024 Q2	8/9/2024	3,418	0.0%	1,146,748	6/30/2024
2024 Q1	5/13/2024	3,098	0.0%	897,965	3/31/2024
2023 Q4	2/13/2024	1,139	0.0%	849,881	12/31/2023
2023 Q3	11/13/2023	1,717	0.0%	787,640	9/30/2023
2023 Q2	8/11/2023	1,861	0.0%	778,821	6/30/2023
2023 Q1	5/15/2023	459	0.0%	248,293	3/31/2023
2022 Q4	2/13/2023	408	0.0%	211,547	12/31/2022
2022 Q3	11/14/2022	308	0.0%	200,221	9/30/2022
2022 Q2	8/12/2022	548	0.0%	195,146	6/30/2022
2022 Q1	5/13/2022	160	0.0%	72,744	3/31/2022
2021 Q4	2/11/2022	38	0.0%	49,077	12/31/2021
2021 Q3	11/12/2021	67	0.0%	49,077	9/30/2021
2021 Q2	8/13/2021	110	0.0%	49,077	6/30/2021
2021 Q1	5/12/2021	133	0.0%	49,077	3/31/2021
2020 Q4	2/12/2021	118	0.0%	49,077	12/31/2020
2020 Q3	11/13/2020	197	0.0%	49,077	9/30/2020
2020 Q2	8/13/2020	275	0.0%	41,913	6/30/2020
2020 Q1	5/14/2020	137	0.0%	41,913	3/31/2020
2019 Q4	2/13/2020	155	0.0%	41,482	12/31/2019